NBIX vs U · P/E 45, rev $2.36B vs rev $1.85B
Neurocrine Biosciences Inc (NBIX) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Unity Software Inc (U) is a software - application company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. U currently screens at market cap $16.98B.
Not investment advice. Open the NBIX and U stock pages for the full models.
Not investment advice.